Cervical cancer risk in HPV ‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up

International Journal of Cancer, EarlyView.

Source: International Journal of Cancer - April 27, 2018 Category: Cancer & Oncology Authors: Lise M.A.De Strooper , JohannesBerkhof , Renske D.M.Steenbergen , Birgit I.Lissenberg ‐Witte , Peter J.F.Snijders , Chris J.L.M.Meijer , Daniëlle A.M.Heideman Source Type: research